SEC Comment Letter 0000000000-24-000761 to Banzai International, Inc. (BNZI)
Banzai International, Inc.
Date: Jan. 19, 2024 · CIK: 0001826011 · Accession: 0000000000-24-000761
AI Filing Summary & Sentiment
File numbers found in text: 333-276307
Show Raw Text
United States securities and exchange commission logo
January 19, 2024
Joseph Davy
Chief Executive Officer
Banzai International, Inc.
435 Ericksen Ave, Suite 250
Bainbridge Island, Washington 98110
Re:Banzai International, Inc.
Registration Statement on Form S-1
Filed December 29, 2023
File No. 333-276307
Dear Joseph Davy:
We have conducted a limited review of your registration statement and have the
following comments.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments.
Registration Statement on Form S-1 Filed December 29, 2023
Cover Page
1.For each of the securities being registered for resale, disclose the price that the selling
securityholders paid or will pay for such securities.
2.Disclose the exercise prices of the warrants compared to the market price of
the underlying securities. Disclose that cash proceeds associated with the exercise of
warrants are dependent on your stock price, that the Public Warrants and the GEM
Warrants are currently out of the money and, therefore, the company is unlikely to receive
proceeds from the exercise of the warrants. Furthermore, the GEM Warrants may be
exercised on a cashless basis, which means the company may not receive cash for the
exercise of the GEM Warrants if they are in the money. Provide similar disclosure in the
prospectus summary, risk factors, MD&A and use of proceeds section. As applicable,
describe the impact on your liquidity and update the discussion on the ability of your
company to fund your operations on a prospective basis with your current cash on hand.
FirstName LastNameJoseph Davy
Comapany NameBanzai International, Inc.
January 19, 2024 Page 2
FirstName LastNameJoseph Davy
Banzai International, Inc.
January 19, 2024
Page 2
3.We note the significant number of redemptions of your Class A common stock in
connection with your business combination and that the shares being registered for resale
will constitute a considerable percentage of your public float. We also note that many of
the shares being registered for resale were purchased by the selling securityholders for
prices considerably below the current market price of the Class A common stock. Please
revise the cover page to highlight that these securityholders have an incentive to sell
because they will profit on sales given that they purchased their shares at more favorable
prices than the public investors. Highlight the significant negative impact sales of shares
on this registration statement could have on the public trading price of the Class A
common stock.
Risk Factors, page 12
4.Include an additional risk factor highlighting the negative pressure potential sales
of shares pursuant to this registration statement could have on the public trading price of
the Class A common stock. To illustrate this risk, disclose the purchase price of
the securities being registered for resale and the percentage that these shares
currently represent of the total number of shares outstanding. Also disclose that even
though the current trading price is significantly below the SPAC IPO price, certain
private investors have an incentive to sell because they will still profit on sales because of
the lower price that they purchased their shares than the public investors.
Sellling Securityholders, page 16
5.Please explain the discrepancies between the selling securityholder table and the
beneficial ownership table with regard to the number of shares beneficially owned by 7GC
& Co. Holdings LLC and ALCO Investment Company.
Management's Discussion and Analysis of Financial Condition and Results of Operations, page
64
6.We note that the projected revenues for Legacy Banzai 2023 were $5.233 million, as set
forth in the unaudited prospective financial information management prepared and
provided to the Board, the company’s financial advisors and the SPAC in connection with
the evaluation of the Business Combination. We also note that actual revenues for the nine
months ended September 30, 2023 were approximately $3.4 million. It appears that you
will miss your 2023 revenue projection. Please revise your disclosure in Liquidity and
Capital Resources, and elsewhere, to provide updated information about the company’s
financial position and further risks to the business operations and liquidity in light of these
circumstances.
Liquidity and Capital Resources, page 78
7.Please discuss the changes in the company's liquidity position and capital resources since
the Business Combination. For example,
FirstName LastNameJoseph Davy
Comapany NameBanzai International, Inc.
January 19, 2024 Page 3
FirstName LastNameJoseph Davy
Banzai International, Inc.
January 19, 2024
Page 3
•disclose the total number of public shares that were redeemed in connection with the
Business Combination and the resulting amount of funds you received from the trust
account;
•disclose the amount of debt and other securities issued, net proceeds received, and
fees paid or payable to finance the company and its obligations in connection with
and following the Business Combination;
•discuss any material changes to the amount, material terms or maturity dates of your
debt;
•discuss how it is unlikely that the company will receive significant proceeds from
exercises of the Public Warrants or GEM Warrants because of the disparity between
the exercise price of these warrants and the current trading price of the Class A
common stock;
•discuss the likelihood that you would be able to have access to the full $100 million
amount under the standby equity purchase agreement with you entered into with
Yorkville in light of your current market price and trading volume;
•disclose that this offering involves the potential sale of a substantial number of shares
for resale and discuss how such sales could impact the market price of the company’s
ordinary shares; and
•disclose that 7GC & Co. Holdings LLC, a beneficial owner of over 29% of your
outstanding shares, and Mr. Joseph Davy, who holds approximately 64.7% of the
company's aggregate voting power, will be able to sell all of their shares for so long
as the registration statement of which this prospectus forms a part is available for use.
Executive and Director Compensation, page 105
8.Please update your executive compensation disclosure to reflect the fiscal year ended
December 30, 2023.
Plan of Distribution, page 137
9.You indicate that the selling securityholders may sell their securities in connection with
short sales. Please clarify that any short sales must be made after effectiveness of the
registration statement. Refer to the Division of Corporation Finance Compliance and
Disclosure Interpretations, Securities Act Sections, Interpretation 139.11
General
10.Revise your prospectus to disclose the price that each selling securityholder paid for the
securities being registered for resale. Highlight any differences in the current trading
price, the prices that the Sponsor, private placement investors, and other selling
securityholders acquired their securities, and the price that the public securityholders
acquired their shares and warrants. Disclose that while the Sponsor, private placement
investors, and other selling securityholders may experience a positive rate of return based
on the current trading price, the public securityholders may not experience a similar rate
of return on the securities they purchased due to differences in the purchase prices and the
FirstName LastNameJoseph Davy
Comapany NameBanzai International, Inc.
January 19, 2024 Page 4
FirstName LastName
Joseph Davy
Banzai International, Inc.
January 19, 2024
Page 4
current trading price. Please also disclose the potential profit the selling securityholders
will earn based on the current trading price. Lastly, please include appropriate risk factor
disclosure.
11.It appears that the GEM Convertible Debenture has not been issued. In this regard, we
note disclosure that it is "to be issued in a private placement to GEM pursuant to that
certain binding term sheet (the 'GEM Term Sheet') dated as of December 13, 2023
between Legacy Banzai and GEM." You also disclose that "the documentation of such
debenture to be agreed upon and finalized promptly following the Closing." However, we
note that neither the Term Sheet nor the documentation of such debenture have been filed
as an exhibit to the current registration statement that registers the shares issuable upon
conversion of the Gem Convertible Debenture. Please advise why you believe it is
appropriate to register the resale of these shares at this time. Refer to the Division of
Corporation Finance Compliance and Disclosure Interpretations, Securities Act
Sections, Question 139.11.
12.Please disclose the material terms of the warrants, notes and debentures that overlie the
securities being registered, including the exercise and conversion prices. If the exercise
and conversion prices are not fixed, describe how the prices are determined.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
Please contact Alexandra Barone at 202-551-8816 or Kathleen Krebs at 202-551-3350
with any other questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Michael P. Heinz, Esq.